AzTrials
AzTrials

Apraxia, IdeomotorNCT05259176

Effects of Transcranial Direct Current Electrical Stimulation on the Recovery of Ideomotor Apraxia of the Upper Limbs

A study testing transcranial Direct Current Stimulation (tDCS) and Behavioural in people with Apraxia, Ideomotor, run by Clinica di Riabilitazione Toscana Spa at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Limbs apraxia is a motor disorder whose characteristic is the inability or difficulty to perform intentional movements of the limbs (gestures), most frequently involving the upper limbs. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Apraxia, Ideomotor
What is being tested?
transcranial Direct Current Stimulation (tDCS) and Behavioural
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteItaly
Study dates
2 Feb 2022to Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects of both gender, with ischaemic stroke;
  • Left hemispheric injury documented by neuroimaging examination;
  • Cerebrovascular disease onset within the first 30 days;
  • Presence of ideomotor apraxia as documented by a score < 53 in the De Renzi's test;
  • Intact semantic skills as documented by normal performance on the Auditory or Visual Word Comprehension subtest of the Neuropsychological Examination for Aphasia (E. N. P. A.);
  • Full comprehension skills as documented by normal performance in the sub-test of oral or orthographic comprehension (Auditory or Visual Words Comprehension) of the Neuropsychological Examination for Aphasia (E. N. P. A.);
Show all 9Show fewer
  • Age between 20 and 80 years;
  • Any schooling;
  • Patient's informed consent signature.

Who cannot join

  • Comprehension and/or semantics deficit as documented by E. N. P. A.;
  • Pre-existing psychiatric and/or neurological pathology;
  • Failure to sign the patient's and/or caregiver's informed consent.

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • CLINICA DI RIABILITAZIONE TOSCANA Spa

    Montevarchi, Arezzo, 52025

    LAURA ABBRUZZESE, +39 3473333750, laura.abbruzzese@libero.it

    CRISTIANO SCARSELLI, +39 3382985555, cristiano.scarselli@gmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Effects of Transcranial Direct Current Electrical Stimulation (tDCS) on the Recovery of Ideomotor Apraxia of the Upper Limbs in Patients With Acute Stroke

Limbs apraxia is a motor disorder whose characteristic is the inability or difficulty to perform intentional movements of the limbs (gestures), most frequently involving the upper limbs. Recent literature indicated promising effects of transcranial direct current stimulation (tDCS) in the recovery of limbs apraxia, showing that, in stroke patients, excitatory anodal tDCS over left inferior parietal lobe (IPL) may improve limb apraxia. Despite this encouraging evidence, the need for larger well powered and sham-controlled clinical trials has also been identified. For these reasons, the objective of this study is to investigate the effects of tDCS application on the left posterior parietal cortex, associated with the treatment for apraxia made by Smania et al. in 2000, on the recovery of the upper limbs ideomotor apraxia in patients with left brain lesion of vascular origin.

Being tested
transcranial Direct Current Stimulation (tDCS), Sham stimulation (sham-tDCS), Behavioural
Keywords
transcranial direct current stimulation, stroke rehabilitation
Medical subject headings
Apraxia, Ideomotor

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transcranial Direct Current Stimulation (tDCS)Device

    Direct current transcranial stimulation will be applied for 20 minutes over the left posterior parietal cortex with an intensity set to 2 mA.

  • Sham stimulation (sham-tDCS)Device

    The same positioning of electrodes as the stimulation condition will be used, but the current will be applied for 30 seconds and then progressively reduced.

  • BehaviouralDevice

    Treatment for upper limbs ideomotor apraxia (Smania et al., 2000)

Study groups in NCT05259176
Study groupRoleWhat they receive
transcranial Direct Current Stimulation (tDCS)Experimentaltranscranial Direct Current Stimulation (tDCS) on the left posterior parietal cortex and rehabilitative treatment with Smania's training
Receives: Device: transcranial Direct Current Stimulation (tDCS); Device: Behavioural
Placebo stimulation (sham-tDCS)Sham comparatorPlacebo stimulation and rehabilitative treatment with Smania's training
Receives: Device: Sham stimulation (sham-tDCS); Device: Behavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes from baseline Ideomotor apraxia test

    It consists of 24 imitation tests carried out with the fingers, the hand and the limb homolateral to the lesion.

    Each gesture is presented up to three times if the production is incorrect, and receives a score of 3 to 0 depending on whether the copy is correct the first, the second, the third time, or never. The test includes 24 gestures, 12 symbolic and 12 non-symbolic, for a total score of 72. Application of the test to over 200 normal subjects showed that the diagnosis of apraxia can be made reliably when the score drops below 53, it's probable, but not certain, for a score between 53 and 62, and it's excluded when the score is greater than 62.

    Measured: The first day of treatment; End of 2nd week; End of 3rd week

  2. Changes from baseline Standardized test for the diagnosis of a selective ideomotor apraxia deficit on the basis of gesture and effector types

    Test for ideomotor apraxia assessment which allows to highlight: 1) the selective deficits for the type of gesture to be imitated and, therefore, specific damage to the two processes underlying the imitation (direct route and semantic pathways) presenting known and new gestures in separate blocks; and 2) deficits of the distal or proximal component of the movements.

    Measured: The first day of treatment; End of 2nd week; End of 3rd week

  3. Changes from baseline Ideational apraxia test

    By placing in front of the patient one object at a time, he is asked to perform the pantomime of use of the object without touching or holding the object itself, but only by looking at it (visual mode). The examiner will assign 2 points if the execution is correct, 1 point if the execution is correct after repetition of the command and 0 points for always incorrect execution. The objects used are: glass, screwdriver, comb, gun, fork, key, rubber, saw, hammer, fan.

    Measured: The first day of treatment; End of 2nd week; End of 3rd week

Secondary outcomes (2)
  1. Changes from baseline Oral apraxia test

    The examiner mimics the 10 bucco-facial movements required by the protocol, and asks the patient to imitate them. If the subject does not perform the task or does not perform it correctly, the therapist repeats the gesture a second time. If, again, the patient does not perform or makes a mistake, the next stimulus is taken. Maximum time for each stimulus is 30 seconds. The gestures to imitate are: show your tongue, whistle, yawn, try to lick your nose, make a partridge, give a kiss, show how your teeth shake when it's cold, snap your tongue making the sound of a galloping horse, blow and scratch your throat. The score is 2 if the execution is accurate on the first attempt, 1 if it is correct on the second attempt and 0 if the gesture is not executed or is not reproduced correctly.

    Measured: The first day of treatment; End of 2nd week; End of 3rd week

  2. Changes from baseline Jebsen-Taylor Hand Functional Assessment Scale

    It is a scale that allows to assess the level of hand function during daily activities. It consists of 7 subtests: writing, turning a page, lifting small objects, pantomime of eating, stacking objects, lifting large and light objects and large and heavy objects. The non-dominant hand will be tested first and then the dominant one. The time for each item will be timed: the final score (total time) will be given by the sum of all the part times: the lower the score, the better the level of hand function.

    Measured: The first day of treatment; End of 2nd week; End of 3rd week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2022
  2. Study start2 Feb 2022
  3. Primary completionMar 2024 (estimated)
  4. Study completionMar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
The present study will be conducted in 2 recruiting centers with a randomized double-blind design. Post-stroke patients with apraxia will be randomly allocated into two parallel groups (Group A and Group B) by creating two randomisation lists of 10 patients which will allow for random and balanced assignment of patient numbers to either Group A or Group B. Group A will undergo direct current transcranial stimulation (tDCS) for 10 consecutive days and online treatment with Smania training. Group B will undergo sham stimulation for 10 consecutive days and online treatment with Smania training.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05259176
Sponsor's protocol ID
tDCS-AIM
Status last verified
Sep 2023
First submitted
15 Feb 2022
Last updated
7 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing transcranial Direct Current Stimulation (tDCS) and Behavioural in people with Apraxia, Ideomotor, run by Clinica di Riabilitazione Toscana Spa at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact LAURA ABBRUZZESE (3473333750, laura.abbruzzese@libero.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes from baseline Ideomotor apraxia test (time frame: The first day of treatment; End of 2nd week; End of 3rd week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in